1. Home
  2. RDHL vs PRZO Comparison

RDHL vs PRZO Comparison

Compare RDHL & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • PRZO
  • Stock Information
  • Founded
  • RDHL 2009
  • PRZO 2014
  • Country
  • RDHL Israel
  • PRZO Israel
  • Employees
  • RDHL N/A
  • PRZO 22
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • PRZO
  • Sector
  • RDHL Health Care
  • PRZO
  • Exchange
  • RDHL Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • RDHL 3.9M
  • PRZO 25.7M
  • IPO Year
  • RDHL N/A
  • PRZO 2023
  • Fundamental
  • Price
  • RDHL $1.51
  • PRZO $1.48
  • Analyst Decision
  • RDHL
  • PRZO
  • Analyst Count
  • RDHL 0
  • PRZO 0
  • Target Price
  • RDHL N/A
  • PRZO N/A
  • AVG Volume (30 Days)
  • RDHL 88.5K
  • PRZO 672.3K
  • Earning Date
  • RDHL 09-05-2025
  • PRZO 08-28-2025
  • Dividend Yield
  • RDHL N/A
  • PRZO N/A
  • EPS Growth
  • RDHL N/A
  • PRZO N/A
  • EPS
  • RDHL N/A
  • PRZO N/A
  • Revenue
  • RDHL $9,550,000.00
  • PRZO $1,007,440.00
  • Revenue This Year
  • RDHL $381.91
  • PRZO N/A
  • Revenue Next Year
  • RDHL N/A
  • PRZO N/A
  • P/E Ratio
  • RDHL N/A
  • PRZO N/A
  • Revenue Growth
  • RDHL 157.62
  • PRZO 80.42
  • 52 Week Low
  • RDHL $1.06
  • PRZO $0.53
  • 52 Week High
  • RDHL $11.70
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 54.23
  • PRZO 53.78
  • Support Level
  • RDHL $1.22
  • PRZO $1.25
  • Resistance Level
  • RDHL $1.60
  • PRZO $1.37
  • Average True Range (ATR)
  • RDHL 0.08
  • PRZO 0.08
  • MACD
  • RDHL 0.04
  • PRZO 0.01
  • Stochastic Oscillator
  • RDHL 76.32
  • PRZO 95.83

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: